You are here: All Products  > Bioheng Completes $80 Million Funding for Allogenic CAR-T Immunotherapies

Bioheng Completes $80 Million Funding for Allogenic CAR-T Immunotherapies

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products